Dan Espinal is the Founder and CEO of Rarebreed Veterinary Partners, a high-growth technology-enabled community of thriving independent veterinary practices. Dan previously ran the IDEXX Laboratories (NASDAQ: IDXX) In-house Chemistry business and Corporate Development & Strategy team, where he managed, led, and executed global acquisitions, managed the annual strategic planning process, and structured complex partnerships. Before IDEXX, Dan was a venture capital investor at Allied Minds, Plc (LSE: ALM), focusing on internet and communication technologies. Prior to Allied Minds, he was a management strategy consultant at JSA Partners (formerly AT Kearney), providing aerospace and defense companies with market entry, competitive strategy, acquisitions and investment decision support, and advisory services. Dan is a U.S. Army combat veteran and airborne-ranger qualified infantry officer with service time as a combat advisor. He led over 150 combat patrols in southeastern Afghanistan and spent time as an executive officer of the 173rd Long Range Surveillance Detachment (Airborne) as an infantry platoon leader. Dan earned his MBA from MIT’s Sloan School of Management.